文献速递慢阻肺

尿锁链素与COPD患者肺气肿严重程度及频繁急性加重相关

Urinary desmosine is associated with emphysema severity and frequent exacerbation in patients with COPD.
PubMed 文献 · Respirology · 2017-09-14

该研究从韩国阻塞性肺疾病队列中选取152例COPD患者,采用液相色谱-串联质谱法检测尿锁链素水平,并按CT肺气肿指数分为肺气肿主导组(n=80)和非肺气肿主导组(n=72)。结果发现肺气肿主导组尿锁链素水平显著更高,高尿锁链素是肺气肿的独立预测因素(相对风险2.6;95%CI 1.11-6.09;P=0.028),且高尿锁链素组随访第一年频繁急性加重者比例显著更高(P=0.041)。

要点

  • 高尿锁链素水平是COPD患者CT肺气肿的独立预测因素(RR 2.6;95%CI 1.11-6.09;P=0.028)。
  • 高尿锁链素组随访第一年频繁急性加重者比例显著更高(P=0.041)。
  • 尿锁链素或可用于识别COPD频繁急性加重患者。

核心结论

  • 采用LC-MS/MS法测定的尿锁链素水平与COPD患者CT肺气肿指数相关,可作为识别频繁急性加重者的有用预测指标。

研究设计与样本

  • 从韩国阻塞性肺疾病队列中选取152例COPD患者,采用液相色谱-串联质谱法(LC-MS/MS)检测尿锁链素。
  • 按CT肺气肿指数将队列分为肺气肿主导组(n=80)和非肺气肿主导组(n=72)。

主要发现

  • 肺气肿主导组尿锁链素水平显著高于非肺气肿主导组,两组间体重指数和肺功能也存在显著差异。
  • 多因素分析显示高尿锁链素水平是肺气肿的显著独立预测因素(相对风险2.6;95%CI 1.11-6.09;P=0.028)。
  • 随访第一年高尿锁链素组频繁急性加重者比例显著更高(P=0.041)。
  • 高尿锁链素组平均急性加重次数更高,但差异无统计学意义(P=0.067)。
  • 随访3年间两组肺气肿指数变化无差异。

临床怎么用

  • 对COPD患者可考虑检测尿锁链素水平,辅助识别肺气肿主导表型及频繁急性加重高风险者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Matrix degradation is a key feature of chronic obstructive pulmonary disease (COPD). Desmosine and isodesmosine (desmosines) are excreted in urine following matrix degradation. The main purpose of this study was to investigate the association between computed tomography (CT) emphysema indices and urinary desmosines in patients with COPD. METHODS: A total of 152 subjects were selected from the Korean Obstructive Lung Disease cohort. Their urine samples were assayed for desmosines using liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods. The cohort was divided into emphysema-dominant (n = 80) and non-emphysema dominant- (n = 72) groups according to the CT emphysema index. RESULTS: The level of urinary desmosines was significantly higher in the emphysema-dominant group. Significant differences were also observed between the two groups for body mass index and lung function. Multivariate analysis indicated that a high level of urinary desmosines was a significant independent predictor of emphysema (relative risk: 2.6; 95% CI: 1.11-6.09; P = 0.028). The percentage of frequent exacerbators was significantly higher in the high urinary desmosine group in the first year of follow-up (P = 0.041). The mean number of exacerbations was higher in the high urinary desmosine group, although this difference was not statistically significant (P = 0.067). The changes in emphysema index did not differ between the two urinary desmosine groups over 3 years of follow-up. CONCLUSION: This study indicates that the level of urinary desmosines measured by LC-MS/MS methods is associated with the CT emphysema index. Urinary desmosine can be a useful predictor in identifying frequent exacerbators.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Kim C, Ko Y, Kim SH, et al. Urinary desmosine is associated with emphysema severity and frequent exacerbation in patients with COPD. Respirology. 2017. PMID: 28905464. doi:10.1111/resp.13170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。